From vaccines to global health to vaccines.
作者信息
Kieny Marie-Paule
机构信息
a Inserm , Paris , France.
出版信息
Hum Vaccin Immunother. 2018;14(11):2550-2552. doi: 10.1080/21645515.2018.1507375. Epub 2018 Sep 14.
Abstract
摘要
相似文献
1
From vaccines to global health to vaccines.从疫苗到全球健康再回到疫苗。
Hum Vaccin Immunother. 2018;14(11):2550-2552. doi: 10.1080/21645515.2018.1507375. Epub 2018 Sep 14.
2
Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples.疫苗可预防疾病的全球最佳疫苗储备设计框架：以麻疹和霍乱疫苗为例进行对比应用
Risk Anal. 2016 Jul;36(7):1487-509. doi: 10.1111/risa.12265. Epub 2014 Aug 11.
3
The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health.疫苗的作用以及为实现公共卫生大融合目标而进行的疫苗决策。
Vaccine. 2017 Jan 20;35 Suppl 1:A10-A15. doi: 10.1016/j.vaccine.2016.10.088. Epub 2016 Dec 22.
4
A global regulatory science agenda for vaccines.疫苗全球监管科学议程
Vaccine. 2013 Apr 18;31 Suppl 2:B163-75. doi: 10.1016/j.vaccine.2012.10.117.
5
The introduction of new vaccines into developing countries II. Vaccine financing.新疫苗引入发展中国家 二、疫苗融资
Vaccine. 2000 Jun 1;18(24):2625-35. doi: 10.1016/s0264-410x(00)00073-6.
6
The global capacity for manufacturing vaccines. Prospects for competition and collaboration among producers in the next decade.全球疫苗生产能力。未来十年生产商之间的竞争与合作前景。
Int J Technol Assess Health Care. 1994 Winter;10(1):39-46. doi: 10.1017/s0266462300013969.
7
The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?全球疫苗免疫联盟：它是国际公共卫生领域公私有效合作的新模式吗？
Am J Public Health. 2004 Nov;94(11):1922-5. doi: 10.2105/ajph.94.11.1922.
8
Vaccines as a global imperative--a business perspective.疫苗：全球当务之急——从商业角度看。
Health Aff (Millwood). 2011 Jun;30(6):1042-8. doi: 10.1377/hlthaff.2011.0338.
9
Human capital gaps in vaccine development: an issue for global vaccine development and global health.疫苗研发中的人力资本差距：全球疫苗研发与全球健康面临的一个问题。
Ann N Y Acad Sci. 2017 May;1395(1):3-11. doi: 10.1111/nyas.13316. Epub 2017 Feb 23.
10
Achieving a "Grand Convergence" in global health by 2035.到2035年在全球健康领域实现“大融合”。
Vaccine. 2017 Jan 20;35 Suppl 1:A2-A5. doi: 10.1016/j.vaccine.2016.10.085. Epub 2016 Dec 22.
本文引用的文献
1
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.新 A 群脑膜炎球菌结合疫苗在非洲成功引入：未来的挑战和下一步措施。
Hum Vaccin Immunother. 2018 May 4;14(5):1098-1102. doi: 10.1080/21645515.2017.1378841. Epub 2017 Nov 8.
2
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).一种重组水疱性口炎病毒载体疫苗预防埃博拉病毒病的有效性和效果：几内亚环状疫苗接种、开放标签、整群随机试验（埃博拉到此为止！）的最终结果
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
3
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer.世卫组织倡议在大流行时增加全球和公平获得流感疫苗的机会：通过技术转让支持发展中国家的生产能力。
Vaccine. 2011 Jul 1;29 Suppl 1:A2-7. doi: 10.1016/j.vaccine.2011.02.079.
4
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.泰国 RV144 HIV 疫苗功效试验的统计解读：功效试验中统计问题的案例研究。
J Infect Dis. 2011 Apr 1;203(7):969-75. doi: 10.1093/infdis/jiq152.
5
Expression of rabies virus glycoprotein from a recombinant vaccinia virus.重组痘苗病毒中狂犬病病毒糖蛋白的表达
Nature. 1984;312(5990):163-6. doi: 10.1038/312163a0.
6
Improved antigenicity of the HIV env protein by cleavage site removal.通过去除裂解位点提高HIV包膜蛋白的抗原性。
Protein Eng. 1988 Sep;2(3):219-25. doi: 10.1093/protein/2.3.219.
7
First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus.
Vet Rec. 1988 Nov 5;123(19):481-3. doi: 10.1136/vr.123.19.481.
Zotero 插件